← Back
$VYNE All transactions

VYNE Therapeutics Inc.

A

$ Value

$927

Shares

1,145

Price

$1

Filed

Jun 3

Insider

Name

Harsch Mutya

Title

CHIEF LEGAL OFFICER AND GC

CIK

0001727809

Roles

Officer

Transaction Details

Transaction Date

2025-06-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

136,646

Footnotes

These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2024 and ending on May 31, 2025 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 30, 2025 (the last trading day of the offering period).

Filing Info

Accession No.

0001415889-25-015383

Form Type

4

Issuer CIK

0001566044

Harsch Mutya's History

Date Ticker Type Value
2026-03-31 VYNE F $2K
2025-12-31 VYNE F $2K
2025-09-30 VYNE F $1K
2025-06-30 VYNE F $6K
2025-06-02 VYNE A $927

Other Insiders at VYNE (90d)

Insider Bought Sold Last
Stuart Iain
CHIEF SCIENTIFIC OFFICER
2026-03-31
Domzalski David
PRESIDENT AND CEO
2026-03-31
Harsch Mutya
CHIEF LEGAL OFFICER AND GC
2026-03-31
Zeronda Tyler
CHIEF FINANCIAL OFFICER
2026-03-31